Literature DB >> 31021222

Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy.

Robert W Link1, Michael R Nonnemacher2,3,4,5, Brian Wigdahl2,3,4,5, Will Dampier1,2,3.   

Abstract

Chronic human immunodeficiency virus type 1 (HIV-1) disease is characterized by the retention of provirus within latently infected cells. Anti-HIV-1 CRISPR-Cas9 gene editing is an attractive strategy to excise or inactivate the HIV-1 genome. Recent strategies have focused on designing gRNAs that target the long terminal repeat (LTR) because 5' and 3' LTR symmetry can facilitate proviral excision. However, the promiscuity of CRISPR-Cas9 gene editing system necessitates the investigation of potential off-target effects. Here, potential gRNAs designed from HIV-1 phylogenetic subtypes using the CRISPRseek tool were investigated. Across the LTR, it was found that certain regions show higher human homology than others. When using recommended cutoffs, 96.40% of gRNAs were predicted to have no high probability off-target effects. Given this observation, while high-probability off-target effects are a potential danger, they can be avoided with proper gRNA design.

Entities:  

Year:  2018        PMID: 31021222      PMCID: PMC6553478          DOI: 10.1089/crispr.2018.0020

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  46 in total

1.  A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain.

Authors:  L Asuncion; B Fogelgren; K S Fong; S F Fong; Y Kim; K Csiszar
Journal:  Matrix Biol       Date:  2001-11       Impact factor: 11.583

2.  Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta.

Authors:  U Kämmerer; A Germeyer; S Stengel; M Kapp; J Denner
Journal:  J Reprod Immunol       Date:  2011-08-15       Impact factor: 4.054

3.  High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.

Authors:  Tricia H Burdo; Michael Nonnemacher; Bryan P Irish; Catherine H Choi; Fred C Krebs; Suzanne Gartner; Brian Wigdahl
Journal:  DNA Cell Biol       Date:  2004-04       Impact factor: 3.311

4.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

5.  Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.

Authors:  Panpan Hou; Shuliang Chen; Shilei Wang; Xiao Yu; Yu Chen; Meng Jiang; Ke Zhuang; Wenzhe Ho; Wei Hou; Jian Huang; Deyin Guo
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

6.  Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.

Authors:  Will Dampier; Neil T Sullivan; Cheng-Han Chung; Joshua Chang Mell; Michael R Nonnemacher; Brian Wigdahl
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

7.  CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets.

Authors:  Shengdar Q Tsai; Nhu T Nguyen; Jose Malagon-Lopez; Ved V Topkar; Martin J Aryee; J Keith Joung
Journal:  Nat Methods       Date:  2017-05-01       Impact factor: 28.547

8.  CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.

Authors:  Satinder Dahiya; Yujie Liu; Michael R Nonnemacher; Will Dampier; Brian Wigdahl
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

9.  HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.

Authors:  Will Dampier; Michael R Nonnemacher; Joshua Mell; Joshua Earl; Garth D Ehrlich; Vanessa Pirrone; Benjamas Aiamkitsumrit; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Jeffrey M Jacobson; Brian Wigdahl
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site.

Authors:  Yujie Liu; Michael R Nonnemacher; Aikaterini Alexaki; Vanessa Pirrone; Anupam Banerjee; Luna Li; Evelyn Kilareski; Brian Wigdahl
Journal:  Clin Med Insights Pathol       Date:  2017-11-15
View more
  6 in total

1.  Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.

Authors:  Cheng-Han Chung; Alexander G Allen; Neil T Sullivan; Andrew Atkins; Michael R Nonnemacher; Brian Wigdahl; Will Dampier
Journal:  Mol Ther       Date:  2019-10-15       Impact factor: 11.454

2.  Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.

Authors:  Robert W Link; Anthony R Mele; Gregory C Antell; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Zsofia Szep; Kim Malone; Jeffrey M Jacobson; Will Dampier; Brian Wigdahl; Michael R Nonnemacher
Journal:  Virus Res       Date:  2019-08-19       Impact factor: 3.303

Review 3.  Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy.

Authors:  Jonathan Herskovitz; Mahmudul Hasan; Milankumar Patel; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing.

Authors:  Neil T Sullivan; Alexander G Allen; Andrew J Atkins; Cheng-Han Chung; Will Dampier; Michael R Nonnemacher; Brian Wigdahl
Journal:  Front Microbiol       Date:  2020-08-12       Impact factor: 5.640

5.  Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients.

Authors:  Neil T Sullivan; Will Dampier; Cheng-Han Chung; Alexander G Allen; Andrew Atkins; Vanessa Pirrone; Greg Homan; Shendra Passic; Jean Williams; Wen Zhong; Katherine Kercher; Mathew Desimone; Luna Li; Gregory C Antell; Joshua Chang Mell; Garth D Ehrlich; Zsofia Szep; Jeffrey M Jacobson; Michael R Nonnemacher; Brian Wigdahl
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

6.  Multiplexed tat-Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape.

Authors:  Youdiil Ophinni; Sayaka Miki; Yoshitake Hayashi; Masanori Kameoka
Journal:  Viruses       Date:  2020-10-28       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.